| Ident. | Authors (with country if any) | Title |
|---|
| 000020 (2021) |
Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie] | [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.] |
| 000046 (2021) |
Paulo Roberto Bignardi [Brésil] ; Carolina Santos Vengrus [Brésil] ; Bruno Matos Aquino [Brésil] ; Alcindo Cerci Neto [Brésil] | Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials. |
| 000089 (2021) |
Kimberley Lewis [Canada] ; Dipayan Chaudhuri [Canada] ; Fayez Alshamsi [Émirats arabes unis] ; Laiya Carayannopoulos [Canada] ; Karin Dearness [Canada] ; Zain Chagla [Canada] ; Waleed Alhazzani [Canada] | The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials. |
| 000091 (2021) |
Fatemeh Sadat Hosseini [Iran] ; Alireza Malektojari [Iran] ; Sara Ghazizadeh [Iran] ; Mehdi Hassaniazad [Iran] ; Parivash Davoodian [Iran] ; Habib Dadvand [Iran] ; Amin Reza Nikpoor [Iran] ; Sara Nikoofal-Sahlabadi [Iran] ; Sara Kahoori [Iran] ; Mojtaba Sepandi [Iran] ; Soheil Hassanipour [Iran] ; Mohammad Fathalipour [Iran] | The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial. |
| 000097 (2021) |
Jack Cook [États-Unis] ; Milton L. Pressler [États-Unis] ; Bharat Damle [États-Unis] ; Demissie Alemayehu [États-Unis] ; Charles A. Knirsch [États-Unis] | The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin. |
| 000113 (2021) |
Tzu-Han Yang [République populaire de Chine] ; Chian-Ying Chou [République populaire de Chine] ; Yi-Fan Yang [République populaire de Chine] ; Chian-Shiu Chien [République populaire de Chine] ; Aliaksandr A. Yarmishyn [République populaire de Chine] ; Tzu-Ying Yang [République populaire de Chine] ; Cheng-Hsuan Liu [République populaire de Chine] ; Kao-Jung Chang [République populaire de Chine] ; Yi-Ping Yang [République populaire de Chine] ; Yuh-Lih Chang [République populaire de Chine] | Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients. |
| 000155 (2021) |
Alberto Enrico Maraolo [Italie] ; Adriano Grossi [Italie] | Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials. |
| 000202 (2021) |
Van Thu Nguyen [France] ; Philippe Rivière [France] ; Pierre Ripoll [France] ; Julien Barnier [France] ; Romain Vuillemot [France] ; Gabriel Ferrand [France] ; Sarah Cohen-Boulakia [France] ; Philippe Ravaud [France] ; Isabelle Boutron [France] | Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials. |
| 000244 (2021) |
Mikaela Smit [Suisse] ; Annalisa Marinosci [Suisse] ; Thomas Agoritsas [Canada] ; Alexandra Calmy [Suisse] | Prophylaxis for COVID-19: a systematic review. |
| 000385 (2021) |
Raina Zhang ; Eleftherios Mylonakis | In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality. |
| 000424 (2021) |
Petri J. Vainio [Finlande] ; Pauliina Hietasalo [Finlande] ; Anna-Liisa Koivisto [Finlande] ; Susanna K Ri Inen [Finlande] ; Jari Turunen [Finlande] ; Mika Virtala [Finlande] ; Jouni Vuorinen [Finlande] ; Mika Scheinin [Finlande] | Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial. |
| 000426 (2021) |
Lucie Pothen [Belgique] ; Halil Yildiz [Belgique] ; Mathilde Mbouck Samnick [Royaume-Uni] ; Jean Cyr Yombi [Belgique] | Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice? |
| 000475 (2021) |
S. Rakedzon [Israël] ; A. Neuberger [Israël] ; A J Domb [Israël] ; N. Petersiel [Israël] ; E. Schwartz [Israël] | From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2? |
| 000478 (2021) |
Hardeep Kaur [Inde] ; Phulen Sarma [Inde] ; Anusuya Bhattacharyya [Inde] ; Manisha Prajapat [Inde] ; Subodh Kumar [Inde] ; Ajay Prakash [Inde] ; Bikash Medhi [Inde] | Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable? |
| 000502 (2021) |
Tatiane Bomfim Ribeiro [Brésil] ; Talita Aona Mazotti [Brésil] ; Nayara Aparecida De Oliveira Silva [Brésil] ; Airton Tetelbom Stein [Brésil] ; Fredi Alexander Diaz-Quijano [Brésil] ; Daniela Oliveira De Melo [Brésil] | Evaluation of the initial response in clinical trial efforts for COVID-19 in Brazil. |
| 000519 (2021) |
Zakariya Kashour [Canada] ; Muhammad Riaz [Pakistan] ; Musa A. Garbati [Nigeria] ; Oweida Aldosary [Arabie saoudite] ; Haytham Tlayjeh [Arabie saoudite] ; Dana Gerberi [États-Unis] ; M Hassan Murad [États-Unis] ; M Rizwan Sohail [États-Unis] ; Tarek Kashour [Arabie saoudite] ; Imad M. Tleyjeh [Arabie saoudite, États-Unis] | Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis. |
| 000521 (2021) |
Daniela R. Junqueira [Canada] ; Brian H. Rowe [Canada] | Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID-19 pandemic. |
| 000565 (2021) |
Iwein Gyselinck [Belgique] ; Laurens Liesenborghs [Belgique] ; Ewout Landeloos [Belgique] ; Ann Belmans [Belgique] ; Geert Verbeke [Belgique] ; Peter Verhamme [Belgique] ; Robin Vos [Belgique] ; W. Janssens [Belgique] | Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial. |
| 000578 (2021) |
Yijia Dong [Royaume-Uni] ; Azwa Shamsuddin [Royaume-Uni] ; Harry Campbell [Royaume-Uni] ; Evropi Theodoratou [Royaume-Uni] | Current COVID-19 treatments: Rapid review of the literature. |
| 000633 (2021) |
Bhagteshwar Singh [Royaume-Uni, Inde] ; Hannah Ryan [Royaume-Uni] ; Tamara Kredo [Afrique du Sud] ; Marty Chaplin [Royaume-Uni] ; Tom Fletcher [Royaume-Uni] | Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. |
| 000740 (2021) |
Viktorija Dragojevic Simic [Serbie] ; Milijana Miljkovic [Serbie] ; Dusica Stamenkovic [Serbie] ; Berislav Vekic [Serbie] ; Nenad Ratkovic [Serbie] ; Radoje Simic [Serbie] ; Nemanja Rancic [Serbie] | An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine. |
